Celera AgGen in Bovine Gene Deal with ViaLactia

ROCKVILLE, Md.--Celera Genomics' AgGen business, in a deal with New Zealand company ViaLactia Biosciences, will search for genes important for dairy productivity in the bovine genome. The deal calls for Celera to use its high-throughput DNA sequencing, library development, and advanced bioinformatics capabilities to identify important expressed genes in dairy cattle. ViaLactia, which has access to cattle populations, related phenotypic information, and knowledge of the dairy industry, plans to use the gene data for integrated breeding programs in New Zealand. Intellectual property resulting from the project will be jointly owned.